Antioxidants No Help for Alzheimer’s, Biomarker Trial Says
milder AD or at-risk, asymptomatic populations.—Esther Landhuis None
379 RESULTS
You searched Esther
Sort By:
milder AD or at-risk, asymptomatic populations.—Esther Landhuis None
weekly intravenous infusions.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3099
treatment, Holtzman told ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3098
could be huge,” he said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3093
whether any of this work relates to cells in their native context,” he told ARF.—Esther Landhuis None
PQN-41 to promote linker cell death.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3076
treatment.” (See full comment below.)—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3070
impairment (see ARF related news story).—Esther Landhuis. This is Part 2 of a two-part story. See Part 1.
dominate,” Herz wrote.—Esther Landhuis. This is Part 1 of a two-part story. See Part 2. None
develop AD therapeutic compounds that promote Aβ clearance without actually entering the brain.—Esther
finding (of a longevity variant) is ApoE, which was reported 15 years ago.”—Esther Landhuis None
they will not specify a protocol for clinicians.—Esther Landhuis None
(see ARF related news story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3037
Thompson said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3031 Alzheimer's Disease
premature aging.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3023 Aging Research Models